Vaxcyte, Inc. (PCVX) Tops Q2 EPS by 5c

Vaxcyte, Inc. (NASDAQ: PCVX) reported Q2 EPS of ($0.70), $0.05 better than the analyst estimate of ($0.75).

For earnings history and earnings-related data on Vaxcyte, Inc. (PCVX) click here.

You May Also Be Interested In

• Morgan Stanley shares gain as equities trading, dealmaking fuel Q2 earnings beat
• Vaxcyte, Inc (PCVX) call put ratio 1.6 calls to 1 put as share price down 2.4%
• Elevance Health Inc. (ELV) Tops Q2 EPS by 124c, raises guidance